Filter By:

Journal Check one or more journals to show results from those journals only.

Choose more journals

Article type Check one or more article types to show results from those article types only.
Subject Check one or more subjects to show results from those subjects only.
Date Choose a date option to show results from those dates only.

Custom date range

Clear all filters
Sort by:
Showing 1–4 of 4 results
Advanced filters: Author: "Robert C. Bast Jr" Clear advanced filters
  • Ovarian cancer that recurs more than 6 months following primary chemotherapy can respond to many different drugs, but retreatment with a combination of carboplatin and paclitaxel has become a standard of care. A combination of pegylated liposomal doxorubicin and carboplatin may provide a slightly, but significantly, greater therapeutic index than carboplatin and paclitaxel.

    • Robert C. Bast Jr
    • Maurie Markman
    News & Views
    Nature Reviews Clinical Oncology
    Volume: 7, P: 559-560
  • Ovarian cancer is a heterogeneous disease, making it difficult to provide standard regimens that are effective for all patients. Can increases in long-term survival be achieved by translating recent insights at the molecular and cellular levels into individual strategies for treatment and optimal early detection?

    • Robert C. Bast Jr
    • Bryan Hennessy
    • Gordon B. Mills
    Reviews
    Nature Reviews Cancer
    Volume: 9, P: 415-428
  • This Opinion article outlines a set of research priorities, based on discussions held at the 2015 Helene Harris Memorial Trust Ovarian Cancer Action meeting, that the authors believe will reduce incidence and improve outcomes for women with high-grade serous ovarian cancer.

    • David D. Bowtell
    • Steffen Böhm
    • Frances R. Balkwill
    Reviews
    Nature Reviews Cancer
    Volume: 15, P: 668-679
  • This Opinion article outlines nine major recommendations for improving our understanding of ovarian cancer and the outcomes of women with this group of diseases.

    • Sebastian Vaughan
    • Jermaine I. Coward
    • Frances R. Balkwill
    Reviews
    Nature Reviews Cancer
    Volume: 11, P: 719-725